• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 000000000000010220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction (2414)
Event Date 11/19/2014
Event Type  Injury  
Event Description
The customer reported that a patient was undergoing a red blood cell exchange (rbcx)procedure and had a transfusion reaction.The rbcs were used as replacement fluid.During mid procedure, the patient developed hives.Per physician's order, benadryl and steroids were administered to the patient.The patient did not require a follow-up visit and was released the same day.The patient is reported in stable condition.Patient identifier is not available at this time.The customer declined to provide patient's weight.The disposable kit is not available for return because it was discarded by the customer.This report is being filed due to medical intervention in the form of benadryl and steroids.
 
Manufacturer Narrative
Investigation: per ther customer, fluids used: 846 ml of rbc's, saline 0.9% and acd-investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to the reaction the patient experienced.The run data file (rdf) was analyzed for this event.Signals in the run data file show that the spectra optia system operated as intended.There is no indication of what may have caused the patient to develop a transfusion reaction during the procedure.The spectra optia apheresis system essentials guide provides the following procedural caution and suggestions to the operator with respect to a patient reaction: the spectra optia system has many safety features.However, a patient reaction can occur rapidly.Therefore, it is imperative that the operator monitor the patient and the system throughout the procedure.In a study referred to within the therapeutics apheresis: a physician¿s handbook, 10% of the procedures experienced a reaction during erythrocytapheresis and 1.6% experienced transfusion reactions.Of the recorded reactions, most were minor and well tolerated.Root cause: based on information provided by the customer and the machine¿s data analysis, the patient¿s transfusion reaction was caused by the rbc product.
 
Event Description
The customer declined to provide patient identifier.The patient's weight was obtained form the run data file analysis (rdf).
 
Manufacturer Narrative
This record was identified during a retrospective review of mdrs to identify records in which an event occurred, but the type of reportable event was not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10811 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key4358543
MDR Text Key5180332
Report Number1722028-2014-00517
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK140151
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 12/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2016
Device Catalogue Number000000000000010220
Device Lot Number11W3205
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/12/2015
Initial Date FDA Received12/23/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/16/2015
07/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/05/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00017 YR
Patient Weight55
-
-